Jake Nysather DO
drjakenysather.bsky.social
Jake Nysather DO
@drjakenysather.bsky.social
Nephrology @UCkidney. Intrests include #TSC, cystic diseases, genetics, AKI/ICU, and #MedSky #NephSky. Father of 3. Sports and food enthusiast. Views are my own.
Reposted by Jake Nysather DO
Happy World Kidney Day!
March 13, 2025 at 10:21 AM
Reposted by Jake Nysather DO
Happy #NephMadness Eve to all who celebrate!
February 28, 2025 at 5:46 PM
Reposted by Jake Nysather DO
1️⃣ We are pleased to announce the publication of the KDIGO 2025 ADPKD Guideline!

This first-ever KDIGO guideline focused on a rare kidney disease provides practical tools to improve diagnosis, care, and treatment.

Read the news release: kdigo.co/2025-ADPKD-G...

#ADPKD
January 21, 2025 at 3:23 PM
Reposted by Jake Nysather DO
1/n HydrANCAzine (hydralazine-induced ANCA-associated vasculitis has turn into an important cause of crescentic glomerulonephritis. Wonder how does hydralazine do it? Here is a tweetorial (BlueSkytorial?). I’ll start with an animation that summarizes and simplifies a proposed mechanism.
December 24, 2024 at 4:59 PM
Reposted by Jake Nysather DO
📟 Consulted a few times last week for, “Is this an RTA?” and my knee-jerk answer is “No”.

📖 The truth is that RTAs are rare though we talk about them a lot in med school. So here are some causes of a non-gap acidosis that are more common than an RTA. A 🧵

#nephsky #emimcc #icusky
December 16, 2024 at 6:17 PM
Reposted by Jake Nysather DO
Celebrating the holidays together! Love our team ❤️ @drjakenysather.bsky.social @zacharysmithmd.bsky.social @jayminbpmd.bsky.social
December 7, 2024 at 6:47 PM
Reposted by Jake Nysather DO
Check out #KDIGOGems 💎 a dynamic new program offering virtual education on the latest @gokdigo.bsky.social Guidelines
#Nephpearls

Register here 👉 gems-gd.org/home
December 5, 2024 at 5:37 PM
Reposted by Jake Nysather DO
1/n happy to share a recent publication from Ochsner Nephrology at Kidney International Reports @kireports.bsky.social Nice visual abstract by Priti Meena.

Link here: www.kireports.org/article/S246...

But let me tell you the story a little bit…
December 5, 2024 at 2:22 AM
Reposted by Jake Nysather DO
Welcome new University of Cincinnati nephro fellows. A fun, rewarding, always interesting experience awaits. Excited to meet everyone. @gudnephron.bsky.social @drjakenysather.bsky.social
December 4, 2024 at 11:15 PM
Reposted by Jake Nysather DO
New today - @thelancet.bsky.social DM/Endo

GLP1RAs and kidney/CV outcomes - SR from @sunilbadve.bsky.social Tuttle, Perkovic et al

www.thelancet.com/journals/lan... ($🔒)

- with/out DM
- kidney outcomes (not albuminuria)
November 25, 2024 at 11:50 PM
Reposted by Jake Nysather DO
👉Before we start, a few reminders! Are you new to #NephJC? Not sure what to do or how this works? Here is a quick rundown.

💡Remember: the simplest rule is to be kind and inclusive while you use your wit!

⏰ We’ll get started in 15min!
November 20, 2024 at 1:45 AM
Reposted by Jake Nysather DO
C3 Glomerulopathy | ERA
www.era-online.org
November 19, 2024 at 12:14 PM
Had a great time with everyone @NKFCincy #DriveForDialysis. Look forward to surprising some patients with some goodies! @govil_amit @UCKidney #NKF
November 15, 2024 at 12:20 AM
Reposted by Jake Nysather DO
Join for the Onconeph education series
#onconeph
November 12, 2024 at 3:27 PM
Reposted by Jake Nysather DO
So folks, one of my primary responsibilities for RPA is to monitor the U.S. Medicare Fee Schedule for nephrology; this will be a thread with key highlights from the 2025 fee schedule which came out November 1. To be transparent, much of this was sent to RPA members yesterday.
November 12, 2024 at 5:47 PM
Reposted by Jake Nysather DO
The most effective pharmacological and hemodynamic intervention for the treatment of hepatorenal syndrome #HRS is a substantial MAP raise, as illustrated in this case example
November 12, 2024 at 2:42 PM